These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9925025)

  • 1. Antibody deposition in the stria vascularis of the MRL-Fas(lpr) mouse.
    Ruckenstein MJ; Hu L
    Hear Res; 1999 Jan; 127(1-2):137-42. PubMed ID: 9925025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrastructural pathology in the stria vascularis of the MRL-Fasl(lpr) mouse.
    Ruckenstein MJ; Keithley EM; Bennett T; Powell HC; Baird S; Harris JP
    Hear Res; 1999 May; 131(1-2):22-8. PubMed ID: 10355601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hearing in the MRL/lpr mouse as a possible model of immune-mediated sensorineural hearing loss.
    Inoue Y; Kanzaki J; Ogawa K; Hashiguchi K; Masuda M
    Eur Arch Otorhinolaryngol; 1998; 255(5):240-3. PubMed ID: 9638465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased cochlear DNA receptor staining in MRL.MpJ-Fas(lpr) autoimmune mice with hearing loss.
    Kaylie DM; Hefeneider SH; Kempton JB; Siess DC; Vedder CT; Merkens LS; Trune DR
    Laryngoscope; 2001 Jul; 111(7):1275-80. PubMed ID: 11568554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strial dysfunction in the MRL-Fas mouse.
    Ruckenstein MJ; Milburn M; Hu L
    Otolaryngol Head Neck Surg; 1999 Oct; 121(4):452-6. PubMed ID: 10504603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow cells as an origin of immune-mediated hearing loss.
    Iwai H; Lee S; Baba S; Tomoda K; Inaba M; Ikehara S; Yamashita T
    Acta Otolaryngol; 2004 Jan; 124(1):8-12. PubMed ID: 14977070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of immunosuppression on the development of cochlear disease in the MRL-Fas(lpr) mouse.
    Ruckenstein MJ; Sarwar A; Hu L; Shami H; Marion TN
    Laryngoscope; 1999 Apr; 109(4):626-30. PubMed ID: 10201753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stria vascularis ultrastructural pathology in the C3H/lpr autoimmune strain mouse: a potential mechanism for immune-related hearing loss.
    McMenomey SO; Russell NJ; Morton JI; Trune DR
    Otolaryngol Head Neck Surg; 1992 Mar; 106(3):288-95. PubMed ID: 1534162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cochlear immunoglobulin in the C3H/lpr mouse model for autoimmune hearing loss.
    Trune DR
    Otolaryngol Head Neck Surg; 1997 Nov; 117(5):504-8. PubMed ID: 9374175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of immune-mediated hearing loss in SCID mice by injection of MRL/lpr mouse spleen cells.
    Iwai H; Tomoda K; Hosaka N; Miyashima S; Suzuka Y; Ikeda H; Lee S; Inaba M; Ikehara S; Yamashita T
    Hear Res; 1998 Mar; 117(1-2):173-7. PubMed ID: 9557987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune disease and cochlear pathology in the C3H/lpr strain mouse.
    Trune DR; Craven JP; Morton JI; Mitchell C
    Hear Res; 1989 Mar; 38(1-2):57-66. PubMed ID: 2708160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic determinants of autoimmune disease and coronary vasculitis in the MRL-lpr/lpr mouse model of systemic lupus erythematosus.
    Gu L; Weinreb A; Wang XP; Zack DJ; Qiao JH; Weisbart R; Lusis AJ
    J Immunol; 1998 Dec; 161(12):6999-7006. PubMed ID: 9862736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL/lpr mice.
    Sekine H; Reilly CM; Molano ID; Garnier G; Circolo A; Ruiz P; Holers VM; Boackle SA; Gilkeson GS
    J Immunol; 2001 May; 166(10):6444-51. PubMed ID: 11342671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow transplantation as a strategy for the treatment of autoimmune hearing loss in MRL/Mp-lpr/lpr mice.
    Iwai H; Lee S; Inaba M; Baba S; Yamashita T; Ikehara S
    J Neuroimmunol; 2005 Nov; 168(1-2):76-82. PubMed ID: 16146652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The MRL-lpr/lpr mouse: a potential model of autoimmune inner ear disease.
    Ruckenstein MJ; Mount RJ; Harrison RV
    Acta Otolaryngol; 1993 Mar; 113(2):160-5. PubMed ID: 8475729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed onset of autoreactive antibody production and M2-skewed macrophages contribute to improved survival of TACI deficient MRL-Fas/Lpr mouse.
    Liu L; Allman WR; Coleman AS; Takeda K; Lin TL; Akkoyunlu M
    Sci Rep; 2018 Jan; 8(1):1308. PubMed ID: 29358664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRL/MP-lpr/lpr mouse as a model of immune-induced sensorineural hearing loss.
    Kusakari C; Hozawa K; Koike S; Kyogoku M; Takasaka T
    Ann Otol Rhinol Laryngol Suppl; 1992 Oct; 157():82-6. PubMed ID: 1416659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cd72(c) is a modifier gene that regulates Fas(lpr)-induced autoimmune disease.
    Xu M; Hou R; Sato-Hayashizaki A; Man R; Zhu C; Wakabayashi C; Hirose S; Adachi T; Tsubata T
    J Immunol; 2013 Jun; 190(11):5436-45. PubMed ID: 23616572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibody responses and pathology regulated by B7-1 and B7-2 costimulation in MRL/lpr lupus.
    Liang B; Kashgarian MJ; Sharpe AH; Mamula MJ
    J Immunol; 2000 Sep; 165(6):3436-43. PubMed ID: 10975864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
    Yasuda T; Yoshimoto T; Tsubura A; Matsuzawa A
    Cell Immunol; 2001 Jun; 210(2):77-86. PubMed ID: 11520074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.